Silence Therapeutics PLC
NASDAQ:SLN
Silence Therapeutics PLC
NASDAQ:SLN
Price:
20.99 USD
-3.76%
Updated:
Jun 3, 2024
Silence Therapeutics PLC
Accumulated Depreciation
|
Silence Therapeutics PLC
Accumulated Depreciation Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Silence Therapeutics PLC
NASDAQ:SLN
|
Accumulated Depreciation
-£3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Accumulated Depreciation
-$462k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Accumulated Depreciation
-$28.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Accumulated Depreciation
-$14.9m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Accumulated Depreciation
-£52.3m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Accumulated Depreciation
-£161.4m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Silence Therapeutics PLC's Accumulated Depreciation?
Accumulated Depreciation
-3m
GBP
-3m
GBP
Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Accumulated Depreciation amounts to -3m GBP.
What is Silence Therapeutics PLC's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 3Y
5%
5%
Over the last year, the Accumulated Depreciation growth was -12%. The average annual Accumulated Depreciation growth rates for Silence Therapeutics PLC have been 5% over the past three years .
You don't have any saved screeners yet
